340 related articles for article (PubMed ID: 21214332)
21. p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
Barresi V; Mondello S; Branca G; Rajan TS; Vitarelli E; Tuccari G
Hum Pathol; 2015 Feb; 46(2):231-8. PubMed ID: 25476123
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
23. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
[TBL] [Abstract][Full Text] [Related]
24. Re-evaluation of the diagnostic performance of
Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001
[TBL] [Abstract][Full Text] [Related]
25. Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.
Nojiri T; Nariai T; Aoyagi M; Senda M; Ishii K; Ishiwata K; Ohno K
J Neurooncol; 2009 Jun; 93(2):233-41. PubMed ID: 19099197
[TBL] [Abstract][Full Text] [Related]
26. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
Ninatti G; Sollini M; Bono B; Gozzi N; Fedorov D; Antunovic L; Gelardi F; Navarria P; Politi LS; Pessina F; Chiti A
Neuro Oncol; 2022 Sep; 24(9):1546-1556. PubMed ID: 35171292
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
28. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
30. (11)C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas.
Okita Y; Nonaka M; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Nakajima S; Kanemura Y
Clin Neurol Neurosurg; 2014 Oct; 125():212-6. PubMed ID: 25178915
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
32. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map.
Coope DJ; Cízek J; Eggers C; Vollmar S; Heiss WD; Herholz K
J Nucl Med; 2007 Dec; 48(12):1971-80. PubMed ID: 18006617
[TBL] [Abstract][Full Text] [Related]
34. [Dynamic11C-methionine PET/CT in differential diagnosis of brain gliomas].
Vikhrova NB; Kalaeva DB; Postnov AA; Khokhlova EV; Konakova TA; Batalov AI; Pogosbekyan EL; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(3):5-13. PubMed ID: 34156203
[TBL] [Abstract][Full Text] [Related]
35. [Utility of 11C-methionine PET/CT in neuro-oncology].
Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
[TBL] [Abstract][Full Text] [Related]
36. PET Imaging of cerebral astrocytoma with 13N-ammonia.
Xiangsong Z; Changhong L; Weian C; Dong Z
J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028
[TBL] [Abstract][Full Text] [Related]
37. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
Hara T; Kondo T; Hara T; Kosaka N
J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
[TBL] [Abstract][Full Text] [Related]
38. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD
Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of [
Hashimoto S; Inaji M; Nariai T; Kobayashi D; Sanjo N; Yokota T; Ishii K; Taketoshi M
Neurol Med Chir (Tokyo); 2019 May; 59(5):176-183. PubMed ID: 30996153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
